EP3615066
Samsetningar af mennskum and-RANKL mótefnum, og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.4.2018EP published:
27.12.2023EP application number:
18724690.5
EP translation filed:
26.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
26.4.2038Expiry date:
26.4.2026Next due date:
30.4.2026
Title in English:
FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAMELanguage of the patent:
English
Timeline
Today
27.4.2018EP application
27.12.2023EP Publication
26.2.2024Translation submitted
15.3.2024Registration published
26.4.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
BRYCH, Stephen, RobertAddress:
Thousand Oaks, CA 91362, US
Name:
WONG, Lyanne, M.Address:
Valencia, CA 91354, US
Name:
FALLON, JaymilleAddress:
Agoura Hills, CA 91301, US
Name:
GOSS, Monica, MichelleAddress:
Newbury Park, CA 91320, US
Name:
GU, Jian, HuaAddress:
Thousand Oaks, CA 91320, US
Name:
GHATTYVENKATAKRISHNA, Pavan, K.Address:
Cambridge, MA 02142, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762492056 PDate:
28.4.2017Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 22.4.2024
Expires: 26.4.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 14.4.2025
Expires: 26.4.2026
Payer: Árnason Faktor ehf.